Discover
CLBT
Cellebrite DI Ltd.
15.45
2 x 11.34
2 x 19.20
bid
ask
+
0.85
5.82%
2 @ 06:13 AM
15.45 +0.00 (0.00%)
| Ytd | -14.31% | |
| 1y | -2.28% |
14.95
day range
15.82
11.02
52 week range
19.98
| Open | 15.00 | Prev Close | 14.60 | Low | 14.95 | High | 15.82 | Mkt Cap | 3.85B |
| Vol | 3.23M | Avg Vol | 2.14M | EPS | 0.28 | P/E | 55.18 | Forward P/E | 22.09 |
| Beta | 1.17 | Short Ratio | 2.42 | Inst. Own | 51.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 13.33 | 200-d Avg | 15.60 | 1yr Est | 21.00 |
| Income Statement | |||
| Total Revenue | 128.30M | ||
| Revenues (USD) | 128.30M | ||
| Cost of Revenue | 22.42M | ||
| Gross Profit | 105.88M | ||
| Operating Expenses | 96.76M | ||
| Research and Development Expense | 35.87M | ||
| Selling, General and Administrative Expense | 60.89M | ||
| Operating Income | 9.12M | ||
| Interest Expense | -4.51M | ||
| Income Tax Expense | 2.70M | ||
| Net Income | 10.94M | ||
| Net Income Common Stock | 10.94M | ||
| Net Income Common Stock (USD) | 10.94M | ||
| Consolidated Income | 10.94M | ||
| Earnings per Basic Share | 0.04 | ||
| Earnings per Basic Share (USD) | 0.04 | ||
| Earnings per Diluted Share | 0.04 | ||
| Earning Before Interest & Taxes (EBIT) | 9.12M | ||
| Earning Before Interest & Taxes (USD) | 9.12M | ||
| Weighted Average Shares | 246.47M | ||
| Weighted Average Shares Diluted | 252.08M | ||
| Balance Sheet | |||
| Cash and Equivalents | 133.69M | ||
| Cash and Equivalents (USD) | 133.69M | ||
| Investments | 400.87M | ||
| Investments Current | 295.38M | ||
| Investments Non-Current | 105.49M | ||
| Trade and Non-Trade Receivables | 72.74M | ||
| Current Assets | 540.87M | ||
| Property, Plant & Equipment Net | 39.55M | ||
| Total Assets | 952.29M | ||
| Debt Current | 4.60M | ||
| Total Debt | 22.81M | ||
| Current Liabilities | 350.21M | ||
| Debt Non-Current | 18.21M | ||
| Total Liabilities | 441.75M | ||
| Accumulated Retained Earnings (Deficit) | -75.60M | ||
| Accumulated Other Comprehensive Income | 992.00K | ||
| Shareholders Equity | 510.54M | ||
| Shareholders Equity (USD) | 510.54M | ||
| Assets Non-Current | 411.42M | ||
| Total Debt (USD) | 22.81M | ||
| Deferred Revenue | 305.24M | ||
| Goodwill and Intangible Assets | 247.53M | ||
| Inventory | 7.53M | ||
| Liabilities Non-Current | 91.54M | ||
| Trade and Non-Trade Payables | 90.52M | ||
| Tax Assets | 11.76M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.01M | ||
| Net Cash Flow from Financing | 3.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.82M | ||
| Capital Expenditure | -3.04M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -15.28M | ||
| Issuance (Purchase) of Equity Shares | 3.51M | ||
| Net Cash Flow from Investing | -13.57M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 11.80M | ||
| Net Cash Flow from Operations | 19.89M | ||
| Effect of Exchange Rate Changes on Cash | -589.00K | ||
| Share Based Compensation | 14.38M | ||